Stress Incontinence/Leaking

18 years or older – Females

The purpose of this study is to assess the safety and effectiveness of the Viveve Study Treatment for females suffering with Urinary Incontinence.

Eligibility

• Symptoms of stress urinary incontinence (release of urine when coughing, sneezing, etc.)
• Pre-menopausal females only
• Body mass index (BMI) of ≤35 kg/m² at the Screening Visit.
• Acceptable form of birth control started at least 3 months prior to screening

Trial Duration

There will be 8 visits to our office over approximately 13 months

Compensation

You will be paid via checks quarterly throughout the trial.